New Advances in Age-Related Macular Degeneration
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: 25 September 2025 | Viewed by 705
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue aims to highlight the latest advancements in our understanding and the management of age-related macular degeneration (AMD), a leading cause of vision loss among older adults. With the increasing prevalence of AMD, it is essential to explore innovative approaches to diagnosis, treatment, and patient care.
We invite submissions that focus on recent research findings, including novel therapeutic interventions, advancements in imaging technologies, and insights into the disease's pathophysiology. Manuscripts may encompass clinical trials, epidemiological studies, and review articles that shed light on emerging treatments.
Our goal is to create a platform for sharing valuable knowledge that can inform clinical practice and improve patient outcomes in AMD. By gathering diverse perspectives and cutting-edge research, this Special Issue seeks to provide a comprehensive understanding of the current landscape of AMD management, ultimately fostering advancements in patient care and preserving vision for those affected by this condition.
Dr. Omer Trivizki
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- wet age-related macular degeneration
- dry age-related macular degeneration
- retinal imaging
- drusen
- intravitreal injections
- ocular angiogenesis
- visual rehabilitation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
